Do you want to read an article? Please log in or register.
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative
Uveitis
Related content
Uveitis
Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic
Br J Ophthalmol.
Agrawal R, Testi I, Lee CS, Tsui E, Blazes M, Thorne JE, Okada AA, Smith JR, McCluskey PJ, Kempen JH, Christoph T, Agarwal M, Bodaghi B, Nguyen QD, Gupta V, De Smet MD, Zierhut M, Pavesio C, COVID-19 IMT Study Group.
doi: 10.1136/bjophthalmol-2020-316776.
Glaucoma and Ocular PressureRetinal DiseasesUveitis
Risk of Ocular Hypertension in Adults with Noninfectious Uveitis
Ophthalmology.
Daniel E, Pistilli M, Kothari S, Khachatryan N, Kaçmaz RO, Gangaputra SS, Sen HN, Suhler EB, Thorne JE, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Bhatt NP, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Research Group
doi: 10.1016/j.ophtha.2017.03.041.
UveitisFurther Publications
Assessing the Uniformity of Uveitis Clinical Concepts and Associated ICD-10 Codes Across Health Care Systems Sharing the Same Electronic Health Records System
JAMA Ophthalmol
McKay KM, Apostolopoulos N, Dahrouj M, Nguyen HV, Reddy A, Blazes M, Lacy M, Pepple KL, Lee AY, Lee CS
doi: 10.1001/jamaophthalmol.2021.2045
RECOMMENDED
Uveitis
Collaborative Ocular Tuberculosis Study (COTS) Consensus Guidelines on the Management of Tubercular Uveitis - Report 2: Guidelines for Initiating Anti-Tubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis and Retinal Vasculitis
★ 3
Recommended by
Prof. Dr Ke Yao, Faculty Member
Ophthalmology.
Agrawal R, Testi I, Bodaghi B, Barisani-Asenbauer T, McCluskey P, Agarwal A, Kempen JH, Gupta A, Smith JR, de Smet MD, Yuen YS, Mahajan S, Kon OM, Nguyen QD, Pavesio C, Gupta V, for COTS CON group.
doi: 10.1016/j.ophtha.2020.06.052.
Uveitis
Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis
JAMA.
Writing Committee for the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group, Kempen JH, Altaweel MM, Holbrook JT, Sugar EA, Thorne JE, Jabs DA
doi: 10.1001/
RECOMMENDED
Uveitis
Association Between Noninfectious Uveitis and Psychological Stress
JAMA Ophthalmol.
Berlinberg EJ, Gonzales JA, Doan T, Acharya NR
doi: 10.1001/jamaophthalmol.
Uveitis
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 1: Guidelines for Initiating Antitubercular Therapy in Tubercular Choroiditis
Ophthalmology.
Agrawal R, Testi I, Mahajan S, Yuen YS, Agarwal A, Kon OM, Barisani-Asenbauer T, Kempen JH, Gupta A, Jabs DA, Smith JR, Nguyen QD, Pavesio C, Gupta V, Collaborative Ocular Tuberculosis Study Consensus Group.
doi: 10.1016/j.ophtha.2020.01.008.
Uveitis
Effect of Adalimumab on Visual Functioning in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis in the VISUAL-1 and VISUAL-2 Trials
JAMA Ophthalmol.
Sheppard J, Joshi A, Betts KA, Hudgens S, Tari S, Chen N, Skup M, Dick AD
Uveitis
Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment: Results from the Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Program
Ophthalmology.
Merrill PT, Clark WL, Banker AS, Fardeau C, Franco P, LeHoang P, Ohno S, Rathinam SR, Ali Y, Mudumba S, Shams N, Nguyen QD, Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Study Group.
doi: 10.1016/j.ophtha.2020.03.033.